Steven Halper
Stock Analyst at Cantor Fitzgerald
(3.08)
# 1,148
Out of 4,789 analysts
72
Total ratings
51.67%
Success rate
8.98%
Average return
Main Sectors:
Stocks Rated by Steven Halper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $11 | $6.98 | +57.59% | 5 | Sep 26, 2023 | |
| NNOX Nano-X Imaging | Reiterates: Overweight | $30 | $5.00 | +500.60% | 11 | Sep 26, 2023 | |
| HCAT Health Catalyst | Reiterates: Overweight | $16 | $4.53 | +253.20% | 4 | Sep 14, 2023 | |
| AMWL American Well | Initiates: Overweight | $300 | $7.88 | +3,707.11% | 1 | Sep 14, 2021 | |
| HQY HealthEquity | Maintains: Overweight | $82 → $85 | $88.37 | -3.81% | 10 | Jun 8, 2021 | |
| OMCL Omnicell | Downgrades: Neutral | n/a | $34.96 | - | 7 | Dec 3, 2020 | |
| ROOT Root, Inc. | Initiates: Overweight | $504 | $133.44 | +277.70% | 1 | Nov 23, 2020 | |
| GOCO GoHealth | Initiates: Overweight | $390 | $12.27 | +3,078.48% | 1 | Aug 10, 2020 | |
| EVH Evolent Health | Downgrades: Neutral | $9 → $8 | $9.47 | -15.52% | 6 | Jun 2, 2020 | |
| TDOC Teladoc Health | Maintains: Neutral | $135 → $145 | $7.96 | +1,721.61% | 8 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $150 → $185 | $6.68 | +2,669.46% | 5 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $245 → $255 | $329.00 | -22.49% | 2 | Feb 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $345 → $400 | $264.60 | +51.17% | 2 | Feb 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $32 | $25.56 | +25.20% | 1 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $83 | $60.71 | +35.89% | 8 | Dec 17, 2018 |
Nyxoah
Sep 26, 2023
Reiterates: Overweight
Price Target: $11
Current: $6.98
Upside: +57.59%
Nano-X Imaging
Sep 26, 2023
Reiterates: Overweight
Price Target: $30
Current: $5.00
Upside: +500.60%
Health Catalyst
Sep 14, 2023
Reiterates: Overweight
Price Target: $16
Current: $4.53
Upside: +253.20%
American Well
Sep 14, 2021
Initiates: Overweight
Price Target: $300
Current: $7.88
Upside: +3,707.11%
HealthEquity
Jun 8, 2021
Maintains: Overweight
Price Target: $82 → $85
Current: $88.37
Upside: -3.81%
Omnicell
Dec 3, 2020
Downgrades: Neutral
Price Target: n/a
Current: $34.96
Upside: -
Root, Inc.
Nov 23, 2020
Initiates: Overweight
Price Target: $504
Current: $133.44
Upside: +277.70%
GoHealth
Aug 10, 2020
Initiates: Overweight
Price Target: $390
Current: $12.27
Upside: +3,078.48%
Evolent Health
Jun 2, 2020
Downgrades: Neutral
Price Target: $9 → $8
Current: $9.47
Upside: -15.52%
Teladoc Health
Apr 15, 2020
Maintains: Neutral
Price Target: $135 → $145
Current: $7.96
Upside: +1,721.61%
Feb 21, 2020
Reiterates: Overweight
Price Target: $150 → $185
Current: $6.68
Upside: +2,669.46%
Feb 6, 2020
Reiterates: Overweight
Price Target: $245 → $255
Current: $329.00
Upside: -22.49%
Feb 5, 2020
Reiterates: Overweight
Price Target: $345 → $400
Current: $264.60
Upside: +51.17%
Jan 9, 2020
Initiates: Overweight
Price Target: $32
Current: $25.56
Upside: +25.20%
Dec 17, 2018
Maintains: Overweight
Price Target: $73 → $83
Current: $60.71
Upside: +35.89%